Skip to content

Public FDA record

Z-0296-2019: FilmArray Blood Culture Identification (BCID), IVD, Rx Only, BioFire Diagnostics, LLC, Panel Catalog Num

Recall record Z-0296-2019 for BioFire Diagnostics, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0296-2019
Company in FDA record
BioFire Diagnostics, LLC
FDA classification date
Oct 30, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Increased risk of false positive results for Proteus when the product is used with a specific blood culture bottles.

Source facts

Action
On 09/05/2018 the firm sent an Urgent Customer Advisory Notice to all customers via Federal Express (to US customers) and USPS (to Laboratory Directors for all organizations that have ordered kits) informing them that the firm has identified an increased risk of false positive Proteus results when the BioFire BCID Panel is used with BACT/ALERT Blood Culture Bottles: BACT/ALERT Blood Culture Bottle Catalog No. Description 410851 BACT/ALERT FA Plus 410852 BACT/ALERT FN Plus 410853 BACT/ALERT PF Plus with expiration dates of 2019-05-02 and beyond. The intended function of BACT/ALERT blood culture bottles (culturing viable microorganisms) is not compromised by this anomaly. BACT/ALERT PF Plus Blood Culture Bottles are included in this notification since they share the same lots of some raw materials used to manufacture implicated lots of BACT/ALERT FA Plus and FN Plus Blood Culture Bottles; there are currently no customer complaints regarding this issue for this bottle type. It is unknown if subsequent lots of BACT/ALERT media will also be subject to this risk; however, BioFire and BioMrieux teams are coordinating efforts to resolve this issue. The most probable cause for this risk is the presence of an increased level of nucleic acid from non-viable Proteus in BACT/ALERT Blood Culture Bottles (Table 1). BioFire has confirmed the presence of Proteus nucleic acid in BacT/ALERT bottle lots using an independent PCR/bi-directional sequencing method. The presence of non-viable organism does not compromise the intended function of the blood culture bottles (culturing viable microorganisms). However, the BioFire BCID Panel detects nucleic acid from viable and non-viable organisms alike. Observed false positives are typically seen as multiple positives with the BioFire BCID Panel because a positive culture is a prerequisite to a BCID test. B
Initiated
2018-09-05
Root cause
Material/Component Contamination
Terminated
2021-03-22
Distribution
Worldwide distribution. US nationwide, Kuwait, Lebanon, Malaysia, Myanmar, Nicaragua, Oman, Panama, Paraguay, Peru, Philippines, Qatar, Romania, Saudi Arabia, Slovenia, Uruguay, United Arab Emirates, Vietnam
Recall number
Z-0296-2019
Recall status
Terminated
CDRH record ID
167368
FDA classified
2018-10-30
Recall event number
81060

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗